Sihuan Bio to Acquire 80% Stake in Changyuan Pharmaceutical for 160 Million Yuan

CLS··CN·Read original
2▲1 ▼0Impact / 5
Summary · why it matters

Sihuan Bio announced that the company plans to acquire an 80% equity stake in Jilin Province Changyuan Pharmaceutical Co., Ltd. in cash, with a transaction price of 160 million yuan. Upon completion of this transaction, Changyuan Pharmaceutical will become a controlling subsidiary of Sihuan Bio. The target company's main products include succinylated gelatin injection and Naoshuankang capsules.

Impact on assets 1

Others▲

Off-coverage companies 1

Jilin Changyuan Pharmaceutical Co., Ltd.i
Private± MixedCapitalrelevance

Changyuan Pharmaceutical is the acquisition target, becoming a controlling subsidiary of Sihuan Bio.